In conclusion, our study demonstrates that G. pentaphyllum, especially its main active compounds, quercetin and rhamnazin, may exert therapeutic effects on NSCLC through the modulation of multiple targets, such as MYC, ESR1, and HIF1A. This evidence concerns the gene HIF1A and non-small cell lung carcinoma.